Drug Industry Tries to Slip $4 Billion Windfall Into Opioid Bill
Drug companies are eyeing a popular opioid bill to roll back discounts for Medicare recipients, but opposition has quickly mobilized.
from NYT > Politics https://ift.tt/2xLF2f5
from NYT > Politics https://ift.tt/2xLF2f5
Comments
Post a Comment